Search results

We identified a novel immuno-oncology target through bacterial metabolites that activate tumor-residing macrophages, triggering a potent anti-tumor response. By leveraging natural metabolic processes, we develop small molecule therapies to enhance the body’s native immune defense against cancer.

Zürich-based health technology company building clinical AI for European primary care. The Jupiter Ecosystem connects an EHR, a patient app and Dia, an AI clinical reasoning layer: AI proposes, the physician decides. ahtida’s live digital clinic is the proprietary data engine.

We develop animal-based products via cell cultivation, combining proprietary animal cell biology with scalable bioprocessing at favorable unit economics. The platform starts with the world's first cultivated whole-cut beef and expands into functional applications, like cell-derived collagen.

Alp Bio AG is a Swiss biotech startup that combines human immune organoid technology with generative AI. The company provides immunogenicity intelligence to detect and mitigate anti-drug antibody (ADA) risks years before clinical trials, helping developers avoid costly late-stage failures.

Apricot BIO is a first-time launcher of a Functional Precision Oncology platform performing deep molecular phenotyping of drug responses for personalised therapy recommendations for early to late-stage clinical decision-making leading to more precise, evidenced-based recommendations for doctors.

arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics. Its flagship MUSE platform provides universal, programmable signal amplification to enable highly sensitive and multiplex assays that drive the future of digital pathology.

Athebio develops ultra-stable biotherapeutics using proprietary Athebody® DARPin molecules with high affinity and specificity. We partner on radiotherapeutics, T cell engagers, targeted delivery (LNP/AAV/oligo) and affinity ligands, enabling breakthrough therapeutic strategies.

Baker McKenzie is an international law firm with offices in Geneva and Zurich, offering top-tier legal advice across all areas of business law. Our team of 130 lawyers provides domestic and international clients with innovative solutions across 74 offices in 45 countries.

Betta Scientific is a Life Sciences consultancy. We support start-ups and established companies in entering international markets. Our clients rely on us to design and execute global go-to-market strategies, build international distribution networks, and accelerate revenue generation across borders.

We at Bioengineering AG design and build customized equipment to improve bioproduction efficiency in biotech, novel food, and biopharma plants. Our engineering teams develop reliable bioreactors and fermenters, from lab scale to production, for clients worldwide. Trusted for over 50 years. In 2025 Bioengineer

Our comprehensive services for early phase drug development, enables you to get your product to market faster. Our state-of-the-art Zürich laboratory focuses on science, compliance and speed to deliver high-quality data analysis. We apply our 40+ years of experience to exceed your expectations.

Cellerys AG is a clinical stage biotechnology company, developing immune tolerance therapeutics for the treatment of multiple sclerosis (MS). Antigenic peptides identified from MS patients are coupled to autologous red blood cells which, when reinfused, restore immune tolerance. in 2021 the company entered a

CellX Biosolutions is a Swiss startup developing bacteria-based solutions to destroy PFAS and other persistent pollutants in water and soil. We discover and optimize rare bacterial degraders to build scalable, sustainable alternatives to costly incineration of chemical waste.

Most cell and stem cell therapies fail beyond blood cancers because delivery cannot preserve function in solid organs. ClexBio’s biological platform enables safe, durable solid tissue replacement, unlocking regenerative therapies for liver failure, type 1 diabetes, and heart disease.

Caidya is a multi-therapeutic clinical research organization serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, we offer a wide range of clinical services and vast therapeutic expertise.

CMC & More delivers hands-on CMC, regulatory, and quality expertise for biotech and pharma. We bridge discovery to first-in-human trials and beyond with GMP-compliant CMC strategies that derisk development and transform complex products into approval-ready assets.

Founded in 1965, Charles River Associates is a leading global consulting firm that provides strategy, financial, and economic consulting services to major law firms, corporations, and governments worldwide. Headquartered in Boston with offices across the globe including Zurich GmbH, CRA has also spent more th

Cradle’s mission is to make engineering biology easier, quicker and more cost-effective. Its enterprise-grade AI software helps scientists engineer better proteins, faster and more successfully, speeding up the development cycle of new therapeutics and bio-based products. Learn more at cradle.bio.

A Swiss life science company, spin-off of UZH, developing personalized skin tissue therapy to treat skin defects and beyond.

DiNABIOS bridges the gap "from lab to life." We offer human-based screening, phenotyping, and services across diverse tissues. Using proprietary 3D tissue engineering and our DiNAQUBE™ platform, we deliver precise efficacy and safety data to de-risk drug development and accelerate clinical success.

DKSH is a global distribution and strategic solutions partner for life science and industrial specialties. We provide innovative and sustainable pharmaceutical and biopharmaceutical ingredients to manufacturers across Asia, Europe, and North America.

DrM Group (Dr. Mueller AG) designs and manufactures advanced filtration systems, vibratory mixers, and single-use technologies for solid/liquid separation and processing. Headquartered in Switzerland, we serve the biotech, pharmaceutical, chemical, and food industries worldwide.

Enantios is a Swiss startup revolutionizing molecular characterization with in-solution structural analysis of chiral complex molecules and biologics. Enantios delivers solutions for quality control and drug development in pharmaceutical, biotech, and chemical industries.

At EY, we are proud to be driven by our purpose to build a better working world, helping to create long-term value for our clients, people, and communities. As a trusted partner, we leverage our experience, knowledge, and services around the world.

Eviden is an Atos business that brings together its digital, cloud and big data & security business lines. It will be a global leader in data-driven, trusted and sustainable digital transformation.

EVIIVE develops single extracellular vesicle-based diagnostics to predict immunotherapy response and monitor tumor microenvironment in real time. Our platform integrates advanced flow analytics and machine learning for precision oncology applications.

evitria provides recombinant antibody production services based on CHO transient expression, focusing on bispecific, Fc-silenced, and afucosylated antibody formats. With over 140,000 transfections, we are a trusted partner for biotech and pharma worldwide.

EvlaBio is a life science startup dedicated to the development of first-in-class therapeutics in the cardiovascular and cardiorenal space. The lead asset is a Therapeutic Monoclonal Antibody (mAb) targeting unphysiological FGFR4/FGF23 cardiac overdrive in the setting of chronic kidney disease (CKD).

We are a Swiss company promoting innovation and technology using our comprehensive and highly qualified expert knowledge. We offer company assessments and consulting and management to support all actors involved in “turning scientific innovation into successful products on the market”.

FIDAI is an AI data intelligence platform streamlining biotech due diligence. We help founders organize complex preclinical and clinical data into audit-ready data rooms, cutting investor review times from months to weeks and bridging the gap between scientific discovery and venture capital.

Fortrea (formerly Labcorp Drug Development/ Covance) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We provide phase I-IV clinical trial management, clinical pharmacology, technology enabled trial solutions and post-approval services.

Future Health Pharma GmbH represents companies in Switzerland and distributes and markets their products in CH, UK and EU. We act as Marketing Authorisation Holder or establish their affiliate in CH and EU. We also hold an establishment license to handle controlled substances (narcotics) & vaccines.

GlycoEra is developing biologics to selectively degrade autoimmune disease causing circulating proteins rapidly, selectively, and deeply while avoiding broader dampening of the immune system. This offers many potential benefits over existing broad-spectrum immune-suppressing therapies.

GMP4U is offering engineering and consulting services for the life sciences industry. As experts in qualification and validation, we support our clients in ensuring GMP compliance for production equipment, laboratory instruments, and information management systems.

Founded in 2012, headcount is a Swiss recruitment agency specializing in Biotech, Medtech, Pharma, and Digital Health. We combine scientific expertise with recruitment excellence to connect top talent with leading companies, ensuring a perfect cultural and professional fit.

Homburger is a Swiss law firm with more than 150 professionals. Homburger advises and represents enterprises and entrepreneurs in all aspects of commercial law – transactions, proceedings and complex cases, in both a domestic and a global context.

Horgen Labs: a life‑science campus on Lake Zurich offering 27,000 m² ready-to-use office, lab & production space plus 50,000 m² expansion land. Scale from startup to global player—near top universities, in a tranquil forest‑to‑lakeshore setting, backed by Swiss stability.

House of Lab Science provides plug-and-play lab infrastructure for biotech and foodtech startups across Switzerland. Our lab-as-a-service model offers ready-to-move-in, certified, well-equipped and affordable labs, helping teams start fast and scale from day one.

We plan and execute industrial building projects for the life sciences industry, in which production processes, building services and architecture are optimally coordinated.

For >100 years, IMPAG has bridged the gap between global producers and the life science industry. As a GMP- and ISO-certified solution provider, we offer sustainable sourcing, expert application consulting, and a curated portfolio of specialty raw materials. Get in touch with us! Together unique!

InSphero is the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. InSphero supports pharmaceutical and biotechnology researchers in successful decision-making by accurately rebuilding healthy and diseased human physiology in vitro.

InterAx is a drug discovery firm spun out of ETHZ. Its Deep Signal platform combines AI with mechanistic cell signaling models to predict how drugs behave inside cells — designing medicines with better efficacy and fewer side effects. Pipeline spans metabolism and oncology, with pharma partnerships.

Jantar is a clinical R/D company in the field of chronic rhinosinusitis. Its asset is dicholine succinate for which clinical proof-of-concept has been established. DISU represents a differentiated new drug with strong safety, rapid efficacy and clear potential for global consumer health leadership.

KennedyFitch is a partner-led collective specialised in Executive Search, People Advisory, and Leadership and Transformation. We work with organisations who want to create impact by building future-fit leadership, strong cultures, and people strategies that support sustainable performance.

Kowa Pharmaceutical Europe AG is part of the Kowa Group, a global enterprise founded in 1894. Backed by over 130 years of innovation and expertise across pharmaceuticals, life sciences, trading, and manufacturing, we create value through quality, trust, and a worldwide network.

Lenz & Staehelin serving global clients from our Geneva, Lausanne and Zurich offices. Our 200+ expert lawyers cover all areas of business law, providing many of the world’s leading companies, organisations and private individuals with insightful, yet always pragmatic and practical, advice.

Life Science Cares Switzerland uses the innovation, financial and human resources of the life science industry to support local charitable projects. Main focus is promoting educational equity by providing young people from socially disadvantaged backgrounds with opportunities in our industry.

LimmaTech Biologics AG is a Swiss clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to protect from the increasing threat of global microbial infections due to emerging antimicrobial resistance (AMR) and sexually transmitted diseases.

LubioScience is the biggest lifescience reagents & services platform in Switzerland. Representing some of the world’s most recognized brands, we provide over 5 million products from more than 120 suppliers and pride ourselves in working with most Swiss biotech companies & start-ups.

Whatever your level of maturity regarding the valorization of data in your company, our Luciders are your trusted advisors to design and implement a data roadmap. We will work closely with your different business units to explore how data, advanced analytics, AI and ML can solve complex challenges.

Mabylon is a clinical-stage company leading innovation in human-derived antibody therapeutics for severe allergies, inflammation, and neurological disorders. MY006, our first-in-class multi-specific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.

MaxWell Biosystems is an electronics-focused life-science company based in Zurich, Switzerland, developing and selling high-content electrophysiology platforms to help our customers in the pharmaceutical industry and in academia make their drug discovery and research more efficient.

MD Bioproducts, with over 30 years of experience, is a worldwide manufacturer and supplier of high-quality antibodies, reagents, peptides, assays, and disease-induction reagents supporting research in arthritis, autoimmune diseases, immunology, inflammation, neurology, metabolism, and oncology.

Memo Therapeutics AG develops therapeutic antibodies for viral infections and cancer. Lead asset potravitug targets BKV in kidney transplant recipients; Phase II SAFE KIDNEY data, presented in Nov 2025, support a planned Phase III start in 2026. MTx is also building an oncology discovery pipeline.

Memorises Bio is a therapeutic antibody discovery company spun out of Memo Therapeutics. We investigate human immune responses and translate them into therapeutic antibodies, combining deep repertoire capture with large-scale functional screening.

MetrioPharm AG, a clinical stage biopharmaceutical development company based in Zurich with a subsidiary in Berlin, Germany, has developed a platform of small molecule drug candidates (oral and i.v.) which targets the modulation of immune cell metabolism without suppressing the immune system.

Miltenyi Biotec Swiss AG is the local subsidiary of Miltenyi Biotec BV&Co KG (Germany). Miltenyi Biotec plays an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.

MUVON is a Swiss, clinical stage biotech company with the goal of revolutionizing the treatment of diseases caused by muscle damage or degradation through the use of the patients' own cells. Our initial area of focus is the treatment of stress urinary incontinence in women (PhII completed).

At Navignostics we characterize tumors using spatial single-cell proteomics. We use unique capabilities to identify a cancer treatment that will optimally fight a tumor. We accelerate cancer drug development by providing key insights into drug mechanisms and tumor features to pharma companies.

There is a new kit on the block. Swiss start-up NEMIS Technologies AG specialises in the development of simple, safe, and on-site pathogen testing solutions. Its detection test for Listeria monocytogenes is already commercially available in Switzerland, France, and Spain.

The Future Rewritten: Unlocking Genome Editing. By fusing directed evolution, high-throughput characterization, and AI, Nerai creates novel CRISPR editors, more precise and more powerful, making gene editing safer and accessible to more patients.

NexMR is a Magritek company providing benchtop NMR solutions to Pharma, Biotech, and Life Science companies. We provide enterprise customer support for benchtop NMR implementation across diverse workflows in the industry: radiochemistry, reaction monitoring, flow chemistry, PAT, screening, and more.

The Nikon Microscope Solutions unit is focused on serving customers in research, biotech/pharma, the clinical laboratory, and academia with industry leading microscope-based imaging solutions. In addtion the Nikon BioImaging Lab, is a CRO that provides microscope-based imaging and analysis services.

NovaGo Therapeutics focuses on two regeneration promoting therapeutics aimed at restoring nerve fibre connections in acute spinal cord injury(SCI) Ph1b clinical trial for SCI was started in Dec 2024 and successful finslaized. PoC studies planned to start mid 2026.

nuantic offers AI-guided lead optimization to biotech and pharma customers developing protein- and peptide-based therapeutics. We're able to optimize affinity, developability and aspects of immunogenicity with outstanding success rates with 10x less effort as compared to traditional methods.

We specialize in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH technology platform, we are fueling a new wave of multi-specific drug candidates engineered with versatility and developability in mind.

ONtrack Biomedical AG is a Swiss spin-off of the University Zurich and University Hospital Zurich which develops in-vitro diagnostic tests for the early and non-invasive detection and monitoring of cancer. Our first product is a urine test for the early detection and monitoring of prostate cancer.

PharmaBlock is a fully integrated CRDMO for small molecules and new modalities of peptides, oligonucleotides, and ADCs. Focused on innovation in chemistry and low-carbon manufacturing, it helps partners accelerate drug R&D, ensure quality, lower costs and support a more sustainable future.

Our goal is to deliver innovations in health care through cutting-edge tech and research, addressing challenges in antimicrobial therapies to improve patient outcomes. We are committed to delivering superior treatments that promote healing and improve quality of life globally.

Procavea Biotech is an ETH Spin-off company developing an innovative protein-based RNA delivery platform. Our focus is to generate siRNA therapeutics in extrahepatic disease areas that are currently unreachable.

As Swiss branch of Promega Corp, Promega AG offers local scientific expertise for 4000+ products covering genomics, proteomics and cell analysis. Promega is a global leader in providing innovative solutions for drug discovery, basic research, human identification, diagnostics and food/water testing.